1. Home
  2. BTMD vs BCTX Comparison

BTMD vs BCTX Comparison

Compare BTMD & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biote Corp.

BTMD

Biote Corp.

HOLD

Current Price

$1.32

Market Cap

39.0M

Sector

Health Care

ML Signal

HOLD

BCTX

BriaCell Therapeutics Corp.

HOLD

Current Price

$4.07

Market Cap

36.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTMD
BCTX
Founded
2012
2014
Country
United States
Canada
Employees
223
4
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.0M
36.6M
IPO Year
2021
2025

Fundamental Metrics

Financial Performance
Metric
BTMD
BCTX
Price
$1.32
$4.07
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$2.83
$40.00
AVG Volume (30 Days)
217.5K
186.3K
Earning Date
05-06-2026
06-15-2026
Dividend Yield
N/A
N/A
EPS Growth
722.22
N/A
EPS
N/A
N/A
Revenue
$192,219,000.00
N/A
Revenue This Year
$2.03
N/A
Revenue Next Year
$6.58
$380.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.27
$2.60
52 Week High
$3.26
$14.68

Technical Indicators

Market Signals
Indicator
BTMD
BCTX
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
BTMD
BCTX

About BTMD Biote Corp.

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.

About BCTX BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Share on Social Networks: